PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation

Preclinical evidence suggests that high-dose hypofractionated ionizing radiation (IR) can enhance anti-tumor immunity and result in significant tumor control when combined with immune checkpoint blockade (ICB). However, low-dose daily fractioned IR used for many tumor types including head and neck s...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncoimmunology
Hlavní autoři: Morisada, Megan, Clavijo, Paul E., Moore, Ellen, Sun, Lillian, Chamberlin, Michael, Van Waes, Carter, Hodge, James W., Mitchell, James B., Friedman, Jay, Allen, Clint T.
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2017
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5790397/
https://ncbi.nlm.nih.gov/pubmed/29399393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1395996
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky